Mesothelin
Mesothelin is a protein biomarker that is often elevated in cancers such as mesothelioma, ovarian cancer, and pancreatic cancer. It aids in the diagnosis and monitoring of these malignancies.
Mesothelin is a protein biomarker used to diagnose and monitor cancers like mesothelioma, ovarian cancer, and pancreatic cancer.
Key facts at a glance
- Units
- nmol/L
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Mesothelin, R&D Systems Mesothelin ELISA
Mesothelin is a cell surface glycoprotein that is normally present in low levels in healthy individuals. However, its expression is significantly increased in several types of cancers, particularly mesothelioma, ovarian cancer, and pancreatic cancer.
The measurement of mesothelin levels in the blood can be used as a diagnostic tool to detect these cancers at an early stage. Elevated levels of mesothelin are often indicative of the presence of malignant tumors.
In addition to diagnosis, monitoring mesothelin levels can help in assessing the effectiveness of treatment and detecting disease recurrence. It is often used in conjunction with other diagnostic tests for a more comprehensive evaluation.
Frequently asked questions
What cancers are associated with elevated mesothelin levels?
How is the mesothelin test performed?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy